Blog
FDA Publishes New Draft Guidance on Reducing Animal Testing in Nonclinical Safety Studies
The U.S. Food and Drug Administration (FDA) on Dec. 2, 2025, issued its draft guidance on Monoclonal Antibodies: Streamlined Nonclinical Safety Studies Guidance for Industry, the agency’s most recent step in reducing animal testing in nonclinical settings….
By: Holland & Knight LLP